Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris

Completed · Phase 2 · Has a placebo group

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to determine whether gevokizumab is effective in the treatment of moderate to severe acne vulgaris.

Key facts

Study ID

NCT01498874

Run by

XOMA (US) LLC

People needed

127

Starts

2011-12-01

Expected to finish

2013-06-01

Last updated by the study team

2014-03-04

Who can join

Age: 17 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of moderate to severe acne vulgaris
• Acne vulgaris unresponsive to oral antibiotics
• Willingness to maintain current habits for facial cleaning, shaving, and application of cosmetics through the end of the study

You may not qualify if…

• Use of medications or treatments from specified pre-treatment time periods through the end of the study
• Beard, moustache, sideburns or other facial hair that may interfere with evaluation
• Other forms of acne
• History of malignancy within 5 years
• History of allergic or anaphylactic reactions to monoclonal antibodies
• History of tuberculosis
• History of chronic systemic infections
• Female subjects who are pregnant, planning to become pregnant
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Study site — Hot Springs, Arkansas, United States
• Study site — Riverside, California, United States
• Study site — San Diego, California, United States
• Study site — Denver, Colorado, United States
• Study site — New Haven, Connecticut, United States
• Study site — Bay City, Michigan, United States
• Study site — Fridley, Minnesota, United States
• Study site — Las Vegas, Nevada, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — Charlotte, North Carolina, United States
• Study site — High Point, North Carolina, United States
• Study site — Raleigh, North Carolina, United States
• Study site — South Euclid, Ohio, United States
• Study site — Portland, Oregon, United States
• Study site — Arlington, Texas, United States
• Study site — Austin, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Salt Lake City, Utah, United States
• Study site — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.